on 22 Aug 2018
Last Applicant/ Owned by
SUNESIS PHARMACEUTICALS INC.
395 Oyster Point Blvd, Suite 400South San Francisco, California94080
US
Serial Number
1611320 filed on 25th Jan 2013
Correspondent Address
GOWLING WLG (CANADA) LLP
SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO
ONTARIO
CA
M5X1G5
Trademark usage description
pharmaceutical preparations for the treatment of tumors, cancers, hematological disorders and hematological malignancies.CIPO Classification Code
Nice
1611320
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 7 on 22nd Aug 2018 | Abandoned - Subsection 40(3) |
Submitted for opposition 12 on 3rd Jan 2018 | Extension of Time |
Submitted for opposition 12 on 14th Jul 2017 | Extension of Time |
Submitted for opposition 12 on 12th Jan 2017 | Extension of Time |
Submitted for opposition 12 on 26th May 2016 | Extension of Time |
Submitted for opposition 67 on 25th Feb 2016 | Agent Name Changed |
Submitted for opposition 68 on 25th Feb 2016 | Rep for Service Name Changed |
Submitted for opposition 12 on 17th Dec 2015 | Extension of Time |
Submitted for opposition 51 on 2th Apr 2015 | Allowance Notice Sent |
Submitted for opposition 50 on 2th Apr 2015 | Allowed |